Cargando…

Ovarian cancer in the older patient: where are we now? What to do next?

In recent years, major advances have been made toward the individualization of epithelial ovarian cancer care, leading to an overall improvement of patient outcomes. However, real-life data indicate that the oldest populations do not benefit from this, due to aspects related to cancer (more aggressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rousseau, Frédérique, Ranchon, Florence, Bardin, Christophe, Bakrin, Naoual, Lavoué, Vincent, Bengrine-Lefevre, Leila, Falandry, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505350/ https://www.ncbi.nlm.nih.gov/pubmed/37724138 http://dx.doi.org/10.1177/17588359231192397

Ejemplares similares

Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO
por: Bengrine, Leila, et al.
Publicado: (2022)

Advances in digital CBT: where are we now, and where next?
por: Thew, Graham R., et al.
Publicado: (2022)

Editorial: Neonatal ECMO in 2019: Where Are We Now? Where Next?
por: Cavallaro, Giacomo, et al.
Publicado: (2022)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
por: Pathan, Mansur K, et al.
Publicado: (2020)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Biliary atresia: Where do we stand now?
por: Govindarajan, Krishna Kumar
Publicado: (2016)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Clinical chorioamnionitis: where do we stand now?
por: Lukanović, David, et al.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
por: Mader, Reuven, et al.
Publicado: (2022)

Critical illness and bone metabolism: where are we now and what is next?
por: Cai, Yun, et al.
Publicado: (2022)

Synthetic Material for Bone, Periodontal, and Dental Tissue Regeneration: Where Are We Now, and Where Are We Heading Next?
por: Cheah, Chia Wei, et al.
Publicado: (2021)

The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?
por: Kalampokas, Theodoros, et al.
Publicado: (2021)

Calculus detection technologies: where do we stand now?
por: Archana, V
Publicado: (2014)

Open Bankart Repair: Where do We Stand Now?
por: Kholinne, Erica, et al.
Publicado: (2019)

Correction: Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
Publicado: (2017)

Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
por: Ramani, Sasirekha, et al.
Publicado: (2016)

Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?
por: Buttgereit, Frank, et al.
Publicado: (2015)

Health in All policies: what do we mean and where are we now?
por: Green, L
Publicado: (2022)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

The Affordable Care Act Insurance Reforms: Where Are We Now, and What’s Next?
por: Borelli, M. Claire, et al.
Publicado: (2016)

Comparative Medicine in the Twenty-First Century: Where are We Now and Where Do We Go from Here?
por: Mobasheri, Ali
Publicado: (2015)

The impact of ICCPR's Global Audit of Cardiac Rehabilitation: where are we now and where do we need to go?
por: Turk-Adawi, Karam, et al.
Publicado: (2023)

FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?
por: Chmiel, Paulina, et al.
Publicado: (2022)

The genetic patterns of bladder cancer. Where do we stand now?
por: Salagierski, Maciej
Publicado: (2013)

The Battle Against COVID-19: Where Do We Stand Now?
por: Negahdaripour, Manica
Publicado: (2020)

Viscoelastic tests in liver disease: where do we stand now?
por: Buliarca, Alina, et al.
Publicado: (2021)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
por: Al Tabaa, Yassine, et al.
Publicado: (2021)

Monkeypox virus crosstalk with HIV; where do we stand now?
por: Shafaati, Maryam, et al.
Publicado: (2022)

Immunity to Avian Leukosis Virus: Where Are We Now and What Should We Do?
por: Feng, Min, et al.
Publicado: (2016)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tlfoeoccqdnufr9u5nnct6v2dg